Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

The effect of increased frequency of hemodialysis on serum cystatin C and β2-microglobulin concentrations: A secondary analysis of the frequent hemodialysis network (FHN) trial.

Huang SS, Kaysen GA, Levin NW, Kliger AS, Beck GJ, Rocco MV, Filler G, Lindsay RM; Frequent Hemodialysis Network (FHN) Group.

Hemodial Int. 2019 Mar 12. doi: 10.1111/hdi.12749. [Epub ahead of print]

PMID:
30861262
2.

Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.

Charytan DM, Himmelfarb J, Ikizler TA, Raj DS, Hsu JY, Landis JR, Anderson AH, Hung AM, Mehrotra R, Sharma S, Weiner DE, Williams M, DiCarli M, Skali H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium.

Kidney Int. 2019 Apr;95(4):973-982. doi: 10.1016/j.kint.2018.08.034. Epub 2018 Nov 23.

PMID:
30473139
3.

Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials.

Chan CT, Kaysen GA, Beck GJ, Li M, Lo J, Rocco MV, Kliger AS; FHN Trials.

Am J Nephrol. 2018;47(3):208-217. doi: 10.1159/000488003. Epub 2018 Apr 5.

4.

Urgent: Stop Preventable Infections Now.

Collins AJ, Kliger AS.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):663-665. doi: 10.2215/CJN.10790917. Epub 2018 Mar 22. No abstract available.

5.

When is more frequent hemodialysis beneficial?

Suri RS, Kliger AS.

Semin Dial. 2018 Jul;31(4):332-342. doi: 10.1111/sdi.12688. Epub 2018 Mar 12. Review.

PMID:
29528138
6.

Targeting Zero Infections in Dialysis: New Devices, Yes, but also Guidelines, Checklists, and a Culture of Safety.

Kliger AS.

J Am Soc Nephrol. 2018 Apr;29(4):1083-1084. doi: 10.1681/ASN.2018020132. Epub 2018 Mar 5. No abstract available.

7.

Using System Inflammatory Response Syndrome as an Easy-to-Implement, Sustainable, and Automated Tool for All-Cause Deterioration Among Medical Inpatients.

Fogerty RL, Sussman LS, Kenyon K, Li F, Sukumar N, Kliger AS, Acker K, Sankey C.

J Patient Saf. 2018 Jan 23. doi: 10.1097/PTS.0000000000000463. [Epub ahead of print]

PMID:
29369071
8.

Long Overdue Need to Reduce Infections with Hemodialysis.

Kliger AS, Collins AJ.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1728-1729. doi: 10.2215/CJN.09280817. Epub 2017 Oct 3. No abstract available.

9.

Thyroid function in end stage renal disease and effects of frequent hemodialysis.

Lo JC, Beck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Li M, Chertow GM; FHN Study.

Hemodial Int. 2017 Oct;21(4):534-541. doi: 10.1111/hdi.12527. Epub 2017 Mar 16.

PMID:
28301073
10.

Symptom Management of the Patient with CKD: The Role of Dialysis.

Cabrera VJ, Hansson J, Kliger AS, Finkelstein FO.

Clin J Am Soc Nephrol. 2017 Apr 3;12(4):687-693. doi: 10.2215/CJN.01650216. Epub 2017 Feb 1. Review.

11.

Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis.

Garg AX, Suri RS, Eggers P, Finkelstein FO, Greene T, Kimmel PL, Kliger AS, Larive B, Lindsay RM, Pierratos A, Unruh M, Chertow GM; Frequent Hemodialysis Network Trial Investigators.

Kidney Int. 2017 Mar;91(3):746-754. doi: 10.1016/j.kint.2016.10.033. Epub 2017 Jan 13.

12.

Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.

Sirich TL, Fong K, Larive B, Beck GJ, Chertow GM, Levin NW, Kliger AS, Plummer NS, Meyer TW; Frequent Hemodialysis Network (FHN) Trial Group.

Kidney Int. 2017 May;91(5):1186-1192. doi: 10.1016/j.kint.2016.11.002. Epub 2017 Jan 12.

PMID:
28089366
13.

Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis.

Lo JC, Beck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Chertow GM; FHN Study.

Hemodial Int. 2017 Apr;21(2):190-196. doi: 10.1111/hdi.12489. Epub 2016 Oct 23.

PMID:
27774730
14.

Peritoneal or hemodialysis for the frail elderly patient, the choice of 2 evils?

Brown EA, Finkelstein FO, Iyasere OU, Kliger AS.

Kidney Int. 2017 Feb;91(2):294-303. doi: 10.1016/j.kint.2016.08.026. Epub 2016 Oct 20. Review.

PMID:
27773426
15.

Introduction of Biosimilar Therapeutics Into Nephrology Practice in the United States: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

Wish JB, Charytan C, Chertow GM, Kalantar-Zadeh K, Kliger AS, Rubin RJ, Yee J, Fishbane S.

Am J Kidney Dis. 2016 Dec;68(6):843-852. doi: 10.1053/j.ajkd.2016.06.022. Epub 2016 Sep 3.

PMID:
27599628
16.

The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials.

Raimann JG, Chan CT, Daugirdas JT, Depner T, Gotch FA, Greene T, Kaysen GA, Kliger AS, Kotanko P, Larive B, Lindsay R, Rocco MV, Chertow GM, Levin NW; Frequent Hemodialysis Network (FHN) Trial Group.

Blood Purif. 2016;41(4):277-86. doi: 10.1159/000441966. Epub 2016 Jan 21.

17.

Long-Term Effects of Frequent In-Center Hemodialysis.

Chertow GM, Levin NW, Beck GJ, Daugirdas JT, Eggers PW, Kliger AS, Larive B, Rocco MV, Greene T; Frequent Hemodialysis Network (FHN) Trials Group.

J Am Soc Nephrol. 2016 Jun;27(6):1830-6. doi: 10.1681/ASN.2015040426. Epub 2015 Oct 14.

18.

Quality Measures for Dialysis: Time for a Balanced Scorecard.

Kliger AS.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):363-8. doi: 10.2215/CJN.06010615. Epub 2015 Aug 27. Review.

19.

Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.

Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Chan C, Pierratos A, Lindsay R, Larive B, Chertow GM, Beck GJ, Eggers PW, Kliger AS; FHN Trial Group.

Am J Kidney Dis. 2015 Sep;66(3):459-68. doi: 10.1053/j.ajkd.2015.02.331. Epub 2015 Apr 8.

20.

Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials.

Kotanko P, Garg AX, Depner T, Pierratos A, Chan CT, Levin NW, Greene T, Larive B, Beck GJ, Gassman J, Kliger AS, Stokes JB; FHN Trial Group.

Hemodial Int. 2015 Jul;19(3):386-401. doi: 10.1111/hdi.12255. Epub 2015 Jan 5.

21.

Maintaining safety in the dialysis facility.

Kliger AS.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):688-95. doi: 10.2215/CJN.08960914. Epub 2014 Nov 6. Review.

22.

Screening for CKD: a pro and con debate.

Kliger AS.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1987. doi: 10.2215/CJN.08990914. Epub 2014 Oct 2. No abstract available.

23.

Effects of frequent hemodialysis on perceived caregiver burden in the Frequent Hemodialysis Network trials.

Suri RS, Larive B, Hall Y, Kimmel PL, Kliger AS, Levin N, Kurella Tamura M, Chertow GM; Frequent Hemodialysis Network (FHN) Trial Group.

Clin J Am Soc Nephrol. 2014 May;9(5):936-42. doi: 10.2215/CJN.07170713. Epub 2014 Apr 10.

24.

Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Yang PC, Rajagopalan S; Frequent Hemodialysis Network Trial Group.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2106-16. doi: 10.2215/CJN.03280313. Epub 2013 Aug 22.

25.

KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.

Kliger AS, Foley RN, Goldfarb DS, Goldstein SL, Johansen K, Singh A, Szczech L.

Am J Kidney Dis. 2013 Nov;62(5):849-59. doi: 10.1053/j.ajkd.2013.06.008. Epub 2013 Jul 25.

PMID:
23891356
26.

Patient perceptions and experiences of ESRD care: quality and satisfaction.

Finkelstein FO, Yalamanchili HB, Kliger AS.

Am J Kidney Dis. 2013 Mar;61(3):366-7. doi: 10.1053/j.ajkd.2012.12.011. No abstract available.

PMID:
23414729
27.

Risk of vascular access complications with frequent hemodialysis.

Suri RS, Larive B, Sherer S, Eggers P, Gassman J, James SH, Lindsay RM, Lockridge RS, Ornt DB, Rocco MV, Ting GO, Kliger AS; Frequent Hemodialysis Network Trial Group.

J Am Soc Nephrol. 2013 Feb;24(3):498-505. doi: 10.1681/ASN.2012060595. Epub 2013 Feb 7.

28.

Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials.

Ornt DB, Larive B, Rastogi A, Rashid M, Daugirdas JT, Hernandez A, Kurella Tamura M, Suri RS, Levin NW, Kliger AS; Frequent Hemodialysis Network Trial Group.

Nephrol Dial Transplant. 2013 Jul;28(7):1888-98. doi: 10.1093/ndt/gfs593. Epub 2013 Jan 27.

29.

Effect of frequent hemodialysis on residual kidney function.

Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS; FHN Trial Group.

Kidney Int. 2013 May;83(5):949-58. doi: 10.1038/ki.2012.457. Epub 2013 Jan 23.

30.

Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials.

Kurella Tamura M, Unruh ML, Nissenson AR, Larive B, Eggers PW, Gassman J, Mehta RL, Kliger AS, Stokes JB; Frequent Hemodialysis Network (FHN) Trial Group.

Am J Kidney Dis. 2013 Feb;61(2):228-37. doi: 10.1053/j.ajkd.2012.09.009. Epub 2012 Nov 11.

31.

Dialysis: Does daily haemodialysis reduce survival?

Kliger AS.

Nat Rev Nephrol. 2013 Jan;9(1):8-9. doi: 10.1038/nrneph.2012.247. Epub 2012 Nov 13. No abstract available.

PMID:
23147761
32.

Effects of frequent hemodialysis on measures of CKD mineral and bone disorder.

Daugirdas JT, Chertow GM, Larive B, Pierratos A, Greene T, Ayus JC, Kendrick CA, James SH, Miller BW, Schulman G, Salusky IB, Kliger AS; Frequent Hemodialysis Network (FHN) Trial Group.

J Am Soc Nephrol. 2012 Apr;23(4):727-38. doi: 10.1681/ASN.2011070688. Epub 2012 Feb 23.

33.

Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S; Frequent Hemodialysis Network (FHN) Trial Group.

Circ Cardiovasc Imaging. 2012 Mar;5(2):251-61. doi: 10.1161/CIRCIMAGING.111.969923. Epub 2012 Feb 23.

34.

Erythropoietic stimulating agents and quality of a patient's life: individualizing anemia treatment.

Kliger AS, Fishbane S, Finkelstein FO.

Clin J Am Soc Nephrol. 2012 Feb;7(2):354-7. doi: 10.2215/CJN.11961111. Epub 2012 Jan 19.

35.

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.

Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS; Frequent Hemodialysis Network (FHN) Trial Group, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S.

Kidney Int. 2011 Nov;80(10):1080-91. doi: 10.1038/ki.2011.213. Epub 2011 Jul 20.

36.

Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials.

Suri RS, Larive B, Garg AX, Hall YN, Pierratos A, Chertow GM, Gorodetskeya I, Kliger AS; FHN Study Group.

Nephrol Dial Transplant. 2011 Jul;26(7):2316-22. doi: 10.1093/ndt/gfr007. Epub 2011 Mar 18.

37.

Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials.

Rocco MV, Larive B, Eggers PW, Beck GJ, Chertow GM, Levin NW, Kliger AS; FHN Trial Group.

Am J Kidney Dis. 2011 Jan;57(1):90-100. doi: 10.1053/j.ajkd.2010.08.024. Epub 2010 Nov 30.

38.

In-center hemodialysis six times per week versus three times per week.

FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS.

N Engl J Med. 2010 Dec 9;363(24):2287-300. doi: 10.1056/NEJMoa1001593. Epub 2010 Nov 20. Erratum in: N Engl J Med. 2011 Jan 6;364(1):93.

39.

More intensive hemodialysis.

Kliger AS.

Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S121-4. doi: 10.2215/CJN.02920509. Review.

40.

Can we improve the quality of life for dialysis patients?

Kliger AS, Finkelstein FO.

Am J Kidney Dis. 2009 Dec;54(6):993-5. doi: 10.1053/j.ajkd.2009.09.005. No abstract available.

PMID:
19932876
41.

Economic factors in nephrology: Core Curriculum 2009.

Kliger AS, Schmidt RJ.

Am J Kidney Dis. 2009 Sep;54(3):572-81. doi: 10.1053/j.ajkd.2009.06.002. No abstract available.

PMID:
19700063
42.

New options to improve hemodialysis patient outcomes.

Kliger AS.

Clin J Am Soc Nephrol. 2009 Apr;4(4):694-5. doi: 10.2215/CJN.00780209. Epub 2009 Apr 1. No abstract available.

43.

Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study.

Jaar BG, Plantinga LC, Crews DC, Fink NE, Hebah N, Coresh J, Kliger AS, Powe NR.

BMC Nephrol. 2009 Feb 6;10:3. doi: 10.1186/1471-2369-10-3.

44.
45.

Frequent nocturnal hemodialysis--a step forward?

Kliger AS.

JAMA. 2007 Sep 19;298(11):1331-3. No abstract available.

PMID:
17878427
46.

Epoetin dosing and dialysis facility ownership.

Kliger AS, Nissenson AR.

JAMA. 2007 Aug 22;298(8):861-2; author reply 862-3. No abstract available.

PMID:
17712067
47.

High-frequency hemodialysis: rationale for randomized clinical trials.

Kliger AS; Frequent Hemodialysis Network Study Group.

Clin J Am Soc Nephrol. 2007 Mar;2(2):390-2. Epub 2006 Dec 20. Review. No abstract available.

48.

The dialysis medical director's role in quality and safety.

Kliger AS.

Semin Dial. 2007 May-Jun;20(3):261-4.

PMID:
17555492
49.

End-stage renal disease measures of quality.

Himmelfarb J, Kliger AS.

Annu Rev Med. 2007;58:387-99. Review.

PMID:
17217331
50.

Frequent Hemodialysis Network (FHN) randomized trials: study design.

Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, Beck GJ, Gassman JJ, Eggers PW, Star RA, Ornt DB, Kliger AS; Frequent Hemodialysis Network Trial Group.

Kidney Int. 2007 Feb;71(4):349-59. Epub 2006 Dec 13.

Supplemental Content

Loading ...
Support Center